Press Play with Madeleine Brand
Diabetes drug Ozempic is costing Medicare billions of dollars
New analysis from the Kaiser Family Foundation shows that Medicare spending on weight loss drugs like Ozempic rose to $5.7 billion in 2022 — up from $57 million in 2018.
By Jonathan Bastian • • 1 min readNew analysis from the Kaiser Family Foundation shows that Medicare spending on weight loss drugs like Ozempic rose to $5.7 billion in 2022 — up from $57 million in 2018.
